The Right Prescription for California? An Analysis of Propositions 78 and 79
Researchers at RAND Health have analyzed the two competing prescription-drug measures on the Nov. 8 ballot — Prop. 79, the measure from consumer groups and unions, and Prop. 78, from the pharmaceutical industry. They conclude that Prop. 79 will enroll more people and bring bigger discounts, but it could also cost the state millions of dollars in Medi-Cal rebates and adversely affect Medi-Cal patients’ access to drugs.
The Right Prescription for California? An Analysis of Propositions 78 and 79